Jonathan Ilicki
Investment Manager
Joined: 2023
Involved in: BOOST Pharma, Gesynta, Elypta, Airsonett
Interests: Diagnostics, HealthTech, MedTech, Therapeutics, BioTech, Digital Health, AI/ML, Life Science

Jonathan is part of Industrifonden’s life science team, bringing experience from healthcare and life science. He has worked clinically as a physician, led research, lectured extensively on evidence-based medicine and also worked as a management consultant at the Boston Consulting Group.
Prior to joining Industrifonden, Jonathan co-founded a medtech startup. He has also built and scaled operations for a digital healthcare provider, and led growth and internationalization for a VC/PE-backed healthtech scaleup. He has coached and been a strategic advisor to several startups.
Jonathan earned his MD from the Karolinska Institute, and his MSc and MBA from the Stockholm School of Economics. He also holds an MA in Evidence-Basing from the University of Gothenburg, and is a Clinical Innovation Fellow at the KTH Royal Institute of Technology.
Jonathan is a voracious reader and avid writer. On his free time he writes for the Swedish Medical Journal and the newsletter Emmetropia.